Conferences  >  Medicine & Healthcare  >  Neurology

Harvard Medical School

How to Rapidly Identify High-Risk Patients and Optimize Their Outcomes: This acclaimed Harvard Medical School CME program provides the latest practice-changing updates and prepares clinicians to evaluate common neurological complaints, quickly and accurately diagnose a neurological emergency, and provide state-of-the-art care for these patients. Designed for both inpatient and outpatient clinicians in the fields of Emergency Medicine, Neurology, Critical Care, Intensive Care, Hospital Medicine, Urgent Care, and Internal or Family Medicine, this course covers evaluation algorithms, detection and diagnosis, imaging best practices, and evidence-based management of high-risk neurological conditions, including comprehensive stroke updates.

Harvard Medical School Postgraduate Medical Education;     Email: CEPrograms@hms.harvard.edu

Harvard, CME, Stroke, TBI, dizziness, weakness, coma, delirium, altered mental status, emergency, neurology, SCI, cauda equina syndrome, spinal cord compression, seizures, back pain, imaging, risk management, algorithms, ICH, hemorrhage, TIA, cerebral aneurysm, headache, RCVS, SDH, SAH, falls, gait, syncope, cerebral venous sinus thrombosis, carotid stenosis

Emergency Medicine & Critical Care,    Continuing Medical Education (CME)

Lumina Organizers

The Ninth MENACTRIMS Congress, scheduled for November 1-2, 2024, at the Jeddah Hilton in Saudi Arabia, is an accredited CME/CPD event. Accreditation is sought from the Saudi Commission for Health Specialties. The congress will feature world-renowned experts discussing the latest advances in multiple sclerosis (MS) research, treatment, and clinical strategies. Organized by Lumina and hosted by MENACTRIMS, this congress offers a platform for healthcare professionals to stay informed on cutting-edge MS care.

Phone: [+961 76802515];     Email: outreach@lumina.ae

Multiple Sclerosis, Neurology, MS Congress, MS Conference, Neurology Conference, Multiple Sclerosis Research, MS CME Conference, CME Conferences Saudi Arabia, MS Treatment, MS Advances

Cleveland Clinic

Despite the availability of more than two dozen anti-seizure medications, there remains a sizable number of patients (between 33% and 54%) who continue to suffer from recurrent seizures. Epilepsy surgery is an available and proven treatment modality for focal epilepsies, but a significant number of patients with multifocal epilepsy or generalized epilepsy are not good surgical candidates. In addition, patients with epilepsy often have difficult to address psychosocial determinants of health such as stress, loss of employment, divorce and psychiatric co-morbidities, including depression, anxiety, PTSD, and psychosis. Therefore, there is an acute need for non-pharmacologic/non-surgical interventions that complement the available traditional treatments for patients with various types of epilepsy. The impact of lifestyle modifications on people with epilepsy is a growing field with various interventions that have shown potential for enhanced care. This inter-disciplinary program will critically review and discuss the current state of nonpharmacologic lifestyle approaches in epilepsy and its co-morbidities by local, national and international experts. In addition, speakers will share best practices learned from treatment of other medical conditions.

Liz Eaton, Education Coordinator;     Phone: [2164455431];     Email: eatonl3@ccf.org

epilepsy, interventions, lifestyle, neurology, complementary medicine, epilepsy research, nutrition

Continuing Medical Education (CME),    Traditional and Alternative Medicine

Cleveland Clinic

Innovations and advances in the field of skull base surgery — including complex anatomy, diagnosis, treatment, and management of complications — continue to occur at a rapid pace, challenging neurosurgeons to stay abreast of the data and their implications for clinical practice. This three day workshop gives attendees hands on experience in different complex approaches as well as discuss the contemporary management issues in patients with skull base pathologies.

Phone: [2164455431];     Email: eatonl3@ccf.org

skull base surgery, skull base, surgery, neurology, neurosurgery, resident, fellow, otolaryngology

Continuing Medical Education (CME),    Surgery

Cleveland Clinic

With the ever-growing therapeutic indications for toxin treatment, increasing numbers of available toxins, and the potential dangers and pitfalls if toxin injections are performed sub-optimally, there is a clear need for a comprehensive training of toxin injection. The clear educational need is for a thorough and intensive training that incorporates balanced and comprehensive didactic lectures, the opportunity to ask questions on uncertain areas, patient demonstrations, and true assessment of understanding of concepts and readiness for injection. This comprehensive course will provide the practicing clinician or clinician-in-training the necessary knowledge needed to competently utilize all types of botulinum toxins, including the use of EMG and ultrasound, all adult and pediatric neurological indications. The course also features toxin injection demonstrations on patients and the opportunity to interact with North American thought-leaders in dystonia and toxin injections with reputations for being exemplary educators.

Phone: [2164455431];     Email: eatonl3@ccf.org

neurotoxin, neurology, injections, toxin treatment, pain management, pharmacology

event lab. GmbH

Unser Symposium richtet sich an ärztliche und medizinisch-technische Kolleg*innen der Radiologie und Neuroradiologie sowie an die Kolleg*innen der Nachbarfächer, insbesondere der Neurologie, Neurochirurgie und der Psychiatrie und bietet Ihnen ein umfangreiches Update in unserem Fachgebiet.

Es erwartet Sie ein spannendes Programm mit Schwerpunkten auf den neurovaskulären und den neurodegenerativen Erkrankungen, der Neuroonkologie, der pädiatrischen Neuroradiologie und der Diagnostik der Wirbelsäule. In Übersichtsvorträgen stellen Ihnen unsere Referent*innen hier die aktuellen Standards und neue methodische Entwicklungen in der Diagnostik und Therapie vor. Wie immer bieten Ihnen unsere interaktiven Fallvorstellungen, Quizformate und Workshops viele Gelegenheiten zur Anwendung Ihres Wissens, zum aktiven Austausch und für Ihre Fragen.

Email: cherrmann@eventlab.org

(pädiatrische) Neuroradiologie, Neurologie, neurodegenerative Erkrankungen, Gefäßanatomie, Neuroonkologie, Rückenmark & Wirbelsäule, neurovaskuläre Erkrankungen

Continuing Medical Education (CME),    Radiology, Nuclear Medicine and Radiation Therapy

Lumina Organizers

GAC 2025, held January 10-12, 2025, in Dubai, UAE, will feature top experts discussing the latest research and treatment in cardiac arrhythmias and electrophysiology.

Email: outreach@lumina.ae

Fusion

Chloe Trundle, Conference Manager;     Email: chloe@fusion-conferences.com

Cancer biology, Cancer modelling, tumor microenvironment, metabolism, immune responses, ageing, metastasis, preclinical trials

Fusion

Rosie Johnson, Conference Manager;     Email: rosie@fusion-conferences.com

Alzheimers disease, neurodegenerative, drug discoveries, AD, genetics, metabolic abnormalities

Deutsche Gesellschaft für Psychotraumatologie e.V. (DeGPT)

Im Rahmen der DeGPT Jahrestagung 2025 wollen wir die komplexen Zusammenhänge zwischen Trauma und Substanzkonsum besser verstehen, den Nutzen und unerwünschte Wirkungen von Substan- zen bei Betroffenen und in der Traumatherapie beleuchten und überlegen, was wir konkret tun können, um die Behandlung von Patient:innen mit Traumafolgestörungen weiter zu verbessern.

Kongressbüro des Instituts für interdisziplinäre Suchtforschung Hamburg;     Phone: [040 7410 57903];     Email: kongress@isd-hamburg.de

Psychotraumatologie, Substanzkonsum, Traumatherapie, Traumafolgestörungen

Psychiatry,    Epidemiology & Public Health

Fusion

Jack Peters, Director;     Email: jack@fusion-conferences.com

Acute leukaemia, leukaemia, blood cancer, cancer biology, myeloid stem cells, myeloid blood cells

We are excited to invite you to the Neuro Biomarkers and Biosignatures (NBB) Conference 2025, taking place from June 9-10, 2025, in the historic city of Rome, Italy. This hybrid event will offer both in-person and virtual participation options, making it accessible to a global audience. Join leading researchers, clinicians, and industry experts as we explore the latest advancements in neuro biomarkers and biosignatures. This conference promises to be a pivotal platform for discussing cutting-edge research, innovative technologies, and emerging trends in the field.

Neuro Biomarkers and Biosignatures, BiomarkerValidation, Molecular and Genetic Biomarkers, Imaging BiomarkersProteomic and Metabolomic, BiomarkersBiomarkers for Neurodegenerative Diseases, Biomarkers in Psychiatric Disorders, Biomarkers in Traumatic Brain Injury, Neuroinflammatory Biomarkers

Optica

Photonics, Optoelectronics and Display Devices,    Healthcare Technologies